We found that c-Met expression was not correlated with clinicopathological features and prognosis of cervical adenocarcinomas, whereas Tsai et al. demonstrated that its overexpression was correlated with poor prognosis [25]. This evidence concerns the gene MET and cervical adenocarcinoma.